Glyceryl monosterate based biodegradable implants for site-specific
delivery of drugs
    1.
    发明授权
    Glyceryl monosterate based biodegradable implants for site-specific delivery of drugs 失效
    基于单体甘油酯的生物可降解植入物用于药物的特异性递送

    公开(公告)号:US5891456A

    公开(公告)日:1999-04-06

    申请号:US885675

    申请日:1997-06-30

    摘要: A method to administer a drug locally to a subject in which biodegradable dosage forms that contain the drug are implanted at a localized site beneath the skin of the subject whereupon the dosage forms release the drug over a desired period of time at a substantially continuous rate. Glyceryl monostearate based compositions that accomplish the method are also provided. Compositions are further provided that affect the release profile or release duration of drugs that are released from the compositions, as are methods that employ these varying release profiles to provide implantable dosage forms that release drugs at a prescribed rate over a prescribed period of time. The compositions are particularly well adapted to implantable dosage forms because they biodegrade quickly to an acceptable level after delivering the drug.

    摘要翻译: 将药物局部施用于其中含有药物的可生物降解剂型的受试者的方法植入受试者皮肤下方的局部位置,由此剂型以基本上连续的速率在期望的时间段内释放药物。 也提供了完成该方法的基于单硬脂酸甘油酯的组合物。 进一步提供影响从组合物释放的药物的释放曲线或释放持续时间的组合物,使用这些变化释放曲线的方法提供在规定时间内以规定速率释放药物的可植入剂型。 组合物特别适合于可植入的剂型,因为它们在递送药物之后快速生物降解至可接受的水平。